Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T10325 | ANI-7
化合物ANI-7
|
931417-26-4 | 98% |
![]() |
ANI-7是芳香烃受体(AhR)途径的激活剂。ANI-7抑制多种癌症细胞的生长,并有效且选择性地抑制MCF-7乳腺癌症细胞的生长(GI50:0.56μM)。 | ||||
T10792L | CHK1-IN-4 hydrochloride
化合物CHK1-IN-4盐酸盐
|
98% |
![]() |
|
CHK1-IN-4 hydrochloride 是有效的checkpoint kinase 1 (chk1) 抑制剂,对肿瘤细胞中 chk1 磷酸化具有有效的抑制作用。CHK1-IN-4 hydrochloride 显示出抗肿瘤活性。 | ||||
T10718L | CCT241533 hydrochloride
化合物 T10718L
|
1431697-96-9 | 98% |
![]() |
CCT241533 hydrochloride is an effective and selective ATP competitive inhibitor of CHK2 (Ki: 1.16 nM; IC50: 3 nM). | ||||
TN1458 | Buddlejasaponin IV
醉鱼草皂苷 Ⅳ
|
139523-30-1 | 98% |
![]() |
Buddlejasaponin IV has analgesic and anti-inflammatory effects, the inhibitions of the expressions of iNOS, COX-2, TNF-alpha, IL-1beta and IL-6 by blocking NF-ka... | ||||
T17223 | VER-00158411
化合物 T17223
|
1174664-88-0 | 98% |
![]() |
VER-00158411 is a checkpoint kinase 1 and CHK2 inhibitor (IC50: 4.4 nM and 4.5 nM, respectively). | ||||
T16165 | Myriocin
多球壳菌素
|
35891-70-4 | 98% |
![]() |
Myriocin is a fungal metabolite isolated from Myriococcum albomyces, Isaria sinclairi and Mycelia sterilia. Myriocin also is an effective inhibitor of serine-pal... | ||||
T10790 | CHK1-IN-2
化合物 T10790
|
912367-45-4 | 98% |
![]() |
CHK1-IN-2 is an inhibitor of checkpoint kinase 1 (CHK1; IC50: 6 nM). | ||||
T16848 | SB-218078
化合物 T16848
|
135897-06-2 | 98% |
![]() |
SB-218078 is less potently inhibits Cdc2 (IC50: 250 nM) and PKC (IC50: 1000 nM). SB-218078 is a potent, ATP-competitive, and cell-permeable checkpoint kinase 1 i... | ||||
T13148 | CHK-IN-1
化合物 T13148
|
1278405-51-8 | 98% |
![]() |
CHK-IN-1 is a CHK1 and CHK2 inhibitor, has anti-proliferative activities. | ||||
T10793 | CHK1 inhibitor
化合物 T10793
|
2097938-64-0 | 98% |
![]() |
CHK1 inhibitor (GDC-0575 analog) is a CHK1 inhibitor. | ||||
T10718 | CCT241533
化合物 T10718
|
1262849-73-9 | 98% |
![]() |
CCT241533 is an effective and selective ATP competitive inhibitor of CHK2 (Ki: 1.16 nM; IC50: 3 nM). | ||||
T14904 | CCT244747
化合物 T14904
|
1404095-34-6 | 98% |
![]() |
CCT244747 is a CHK1 inhibitor (IC50: 7.7 nM) and also abrogates G2 checkpoint (IC50: 29 nM). | ||||
T10792 | CHK1-IN-4
化合物 T10792
|
2120398-41-4 | 98% |
![]() |
CHK1-IN-4 is a potent inhibitor of checkpoint kinase 1 (chk1) and potently inhibits chk1 phosphorylation in the tumor cells with anti-tumor activity. | ||||
T11960 | MBM-55
化合物MBM-55
|
2083622-09-5 | 98% |
![]() |
MBM-55 是一种有效的中心体相关激酶 2 (NEK2) 抑制剂,IC50 为 1 nM。 MBM-55 通过诱导细胞周期停滞和凋亡有效抑制癌细胞的增殖。 | ||||
T9252 | LY2880070
化合物LY2880070
|
1375637-35-6 | 98% |
![]() |
LY2880070 是一种用于癌症治疗的新型检查点激酶 1 (CHK1) 抑制剂。 | ||||
T3700 | SCH900776 (S-isomer)
化合物SCH900776 S-isomer
|
891494-64-7 | 98% |
![]() |
SCH900776 S-isomer 是SCH900776的S 型同分异构体。 | ||||
T2485 | Baricitinib
巴瑞克替尼
|
1187594-09-7 | 98% |
![]() |
Baricitinib 是一种选择性,可口服的JAK1和JAK2抑制剂,IC50分别为5.9 nM 和 5.7 nM,具有潜在的抗炎、免疫调节和抗肿瘤活性。 | ||||
T10406 | Tuvusertib
化合物Tuvusertib
|
1613200-51-3 | 98% |
![]() |
Tuvusertib 是一种可口服的共济失调毛细血管扩张和 Rad3相关(ATR)激酶抑制剂(Ki< 1 µΜ),具有选择性和潜在的抗肿瘤活性。Tuvusertib 选择性抑制 ATR 活性,阻断丝氨酸/苏氨酸蛋白激酶检查点激酶1 (CHK1)的下游磷酸化,从而抑制 DNA 损伤检查点激活,破坏 DNA 损伤修复,诱导肿... | ||||
T6931 | PD0166285
化合物PD0166285
|
185039-89-8 | 98% |
![]() |
PD0166285是 P-gp 的底物,是一种有效的 Wee1 和 Chk1 抑制剂弱抑制。 | ||||
T1837 | BX-912
化合物BX912
|
702674-56-4 | 98% |
![]() |
BX-912 是一种直接的,选择性的,ATP 竞争性的PDK1抑制剂,IC50值为 26 nM。它阻断肿瘤细胞 PDK1/Akt 信号转导,抑制多种肿瘤细胞株的锚定依赖性生长或诱导凋亡。 |